ArticleJournal of medical virology2021

SARS-CoV-2 S1 is superior to the RBD as a COVID-19 subunit vaccine antigen.

Yunfei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.